BRCA2 reversion mutation confers resistance to olaparib in
breast cancer
Shinya Yamamoto1, Kei Kawashima1Yoshie Fujiwara1, Shoko Adachi1,
Kazutaka Narui1, Chiaki Hosaka2,
Rina Takahashi2, Sho Tsuyuki3,
Makoto Sugimori3, Miki Tanoshima2,
Mahato Sasamoto4, Masanori Oshi4,
Akimitsu Yamada4, Chikara Kunisaki3,
Itaru Endo4
1 Department of Breast and Thyroid Surgery, Yokohama
City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama
City, Kanagawa 232-0024, Japan
2 Department of Clinical Genetics, Yokohama City
University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama City,
Kanagawa 232-0024, Japan
3 Department of Cancer Genome Medicine, Yokohama City
University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama City,
Kanagawa 232-0024, Japan
4 Department of Gastroenterological Surgery, Yokohama
City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku,
Yokohama City, Kanagawa 236-0004, Japan